Impaired Antibody-Dependent Cellular Cytotoxicity in a Spanish Cohort of Patients With COVID-19 Admitted to the ICU

por Vigón, Lorena, García-Pérez, Javier, Rodríguez-Mora, Sara, Torres, Montserrat, Mateos, Elena, Castillo de la Osa, María, Cervero, Miguel, Malo De Molina, Rosa, Navarro, Cristina, Murciano-Antón, María Aránzazu, García-Gutiérrez, Valentín, Planelles, Vicente, Alcamí, José, Pérez-Olmeda, Mayte, Coiras, Mayte, López-Huertas, María Rosa
Publicado 2021

Strong Cellular Immune Response, but Not Humoral, against SARS-CoV-2 in Oncohematological Patients with Autologous Stem Cell Transplantation after Natural Infection

por Vigón, Lorena, Sánchez-Tornero, Adrián, Rodríguez-Mora, Sara, García-Pérez, Javier, Corona de Lapuerta, Magdalena, Pérez-Lamas, Lucía, Casado-Fernández, Guiomar, Moreno, Gemma, Torres, Montserrat, Mateos, Elena, Murciano-Antón, María Aránzazu, Alcamí, José, Pérez-Olmeda, Mayte, López-Jiménez, Javier, García-Gutiérrez, Valentín, Coiras, Mayte
Publicado 2022

Early Cellular and Humoral Responses Developed in Oncohematological Patients after Vaccination with One Dose against COVID-19

por Rodríguez-Mora, Sara, Corona, Magdalena, Torres, Montserrat, Casado-Fernández, Guiomar, García-Pérez, Javier, Ramos-Martín, Fernando, Vigón, Lorena, Manzanares, Mario, Mateos, Elena, Martín-Moro, Fernando, Zurdo-Castronuño, Alejandro, Murciano-Antón, María Aranzazu, Alcamí, José, Pérez-Olmeda, Mayte, López-Jiménez, Javier, García-Gutiérrez, Valentín, Coiras, Mayte
Publicado 2022

Durable treatment-free remission in patients with chronic myeloid leukemia in chronic phase following frontline nilotinib: 96-week update of the ENESTfreedom study

por Ross, David M., Masszi, Tamas, Gómez Casares, María Teresa, Hellmann, Andrzej, Stentoft, Jesper, Conneally, Eibhlin, Garcia-Gutierrez, Valentin, Gattermann, Norbert, le Coutre, Philipp D., Martino, Bruno, Saussele, Susanne, Giles, Francis J., Radich, Jerald P., Saglio, Giuseppe, Deng, Weiping, Krunic, Nancy, Bédoucha, Véronique, Gopalakrishna, Prashanth, Hochhaus, Andreas
Publicado 2018

Identification of Immunological Parameters as Predictive Biomarkers of Relapse in Patients with Chronic Myeloid Leukemia on Treatment-Free Remission

por Vigón, Lorena, Luna, Alejandro, Galán, Miguel, Rodríguez-Mora, Sara, Fuertes, Daniel, Mateos, Elena, Piris-Villaespesa, Miguel, Bautista, Guiomar, San José, Esther, Rivera-Torres, José, Steegmann, Juan Luis, de Ory, Fernando, Pérez-Olmeda, Mayte, Alcamí, José, Planelles, Vicente, López-Huertas, María Rosa, García-Gutiérrez, Valentín, Coiras, Mayte
Publicado 2020

Characterization of the Early Humoral and Cellular Response Developed in Oncohematological Patients Post-Vaccination with One Dose Against COVID-19

por Corona De Lapuerta, Magdalena, Rodriguez-Mora, Sara, Casado-Fernandez, Guiomar, Garcia-Pérez, Javier, Vigon, Lorena, Murciano-Antón, María Aranzazú, Blanchard, María Jesús, Marquet Palomanes, Juan, Martin Moro, Fernando, Palomo Rumschisky, Pablo, Pérez-Olmeida, Mayte, López Jiménez, Javier, López-Huertas, Maria Rosa, Coiras, Maria Teresa, Garcia Gutierrez, Valentín
Publicado 2021

Analysis of Immunological and Clinical Response to Vaccination Against Sars-COV-2 in Patients with Chronic Myeloid Leukemia

por ZURDO Castronuño, Alejandro, Solera Sainero, Miriam, Corona, Magdalena, Torres, Monserrat, Casado-Fernandez, Guiomar, Ramos-García, Fernando, Garcia-Pérez, Javier, Murciano-Antón, María Aranzazú, Blanchard, María Jesús, Marquet Palomanes, Juan, Martin Moro, Fernando, Pérez-Olmeida, Mayte, López Jiménez, Javier, Coiras, Maria Teresa, Rodriguez-Mora, Sara, Garcia-Gutiérrez, Valentín
Publicado 2022

Nilotinib first-line therapy in patients with Philadelphia chromosome-negative/BCR-ABL-positive chronic myeloid leukemia in chronic phase: ENEST1st sub-analysis

por Hochhaus, Andreas, Mahon, Franҫois-Xavier, le Coutre, Philipp, Petrov, Ljubomir, Janssen, Jeroen J. W. M., Cross, Nicholas C. P., Rea, Delphine, Castagnetti, Fausto, Hellmann, Andrzej, Rosti, Gianantonio, Gattermann, Norbert, Coronel, Maria Liz Paciello, Gutierrez, Maria Asuncion Echeveste, Garcia-Gutierrez, Valentin, Vincenzi, Beatrice, Dezzani, Luca, Giles, Francis J.
Publicado 2017

PTCH1 is a reliable marker for predicting imatinib response in chronic myeloid leukemia patients in chronic phase

por Alonso-Dominguez, Juan M., Casado, Luis Felipe, Anguita, Eduardo, Gomez-Casares, Maria Teresa, Buño, Ismael, Ferrer-Marín, Francisca, Arenas, Alicia, Del Orbe, Rafael, Ayala, Rosa, Llamas, Pilar, Salgado, Rocio N., Osorio, Santiago, Sanchez-Godoy, Pedro, Burgaleta, Carmen, Mahíllo-Fernández, Ignacio, Garcia-Gutierrez, Valentin, Steegmann, Juan Luis, Martinez-Lopez, Joaquín
Publicado 2017

Bosutinib versus imatinib for newly diagnosed chronic phase chronic myeloid leukemia: final results from the BFORE trial

por Brümmendorf, Tim H., Cortes, Jorge E., Milojkovic, Dragana, Gambacorti-Passerini, Carlo, Clark, Richard E., le Coutre, Philipp, Garcia-Gutierrez, Valentin, Chuah, Charles, Kota, Vamsi, Lipton, Jeffrey H., Rousselot, Philippe, Mauro, Michael J., Hochhaus, Andreas, Hurtado Monroy, Rafael, Leip, Eric, Purcell, Simon, Yver, Anne, Viqueira, Andrea, Deininger, Michael W.
Publicado 2022

An analysis of the kinetics of molecular response during the first trimester of treatment with nilotinib in newly diagnosed chronic myeloid leukemia patients in chronic phase

por Steegmann, Juan Luis, Colomer, Dolors, Gómez-Casares, Maria-Teresa, García-Gutiérrez, Valentín, Ortí, Guillermo, Ramírez-Payer, Angel, Olavarria, Eduardo, Vall-llovera, Ferrán, Giraldo, Pilar, Conde, Eulogio, Vallansot, Rolando, López-Lorenzo, Jose Luis, Palomera, Luis, Álvarez-Larrán, Alberto, Conesa, Venancio, Bautista, Guiomar, Casas, Laura, Giles, Frank, Hochhaus, Andreas, Casado-Montero, Luis Felipe
Publicado 2017

Correction to: An analysis of the kinetics of molecular response during the first trimester of treatment with nilotinib in newly diagnosed chronic myeloid leukemia patients in chro...

por Steegmann, Juan Luis, Colomer, Dolors, Gómez-Casares, Maria-Teresa, García-Gutiérrez, Valentín, Ortí, Guillermo, Ramírez-Payer, Angel, Olavarria, Eduardo, Vall-llovera, Ferrán, Giraldo, Pilar, Conde, Eulogio, Vallansot, Rolando, López-Lorenzo, Jose Luis, Palomera, Luis, Álvarez-Larrán, Alberto, Conesa, Venancio, Bautista, Guiomar, Casas, Laura, Giles, Frank, Hochhaus, Andreas, Casado-Montero, Luis Felipe
Publicado 2017

P680: PONATINIB 15 MG AS CONSOLIDATION PRIOR TO TREATMENT FREE REMISSION IN CHRONIC MYELOID LEUKEMIA

por Garcia Gutierrez, Valentin, Carlos Hernandez-Boluda, Juan, Felipe Casado Montero, Luis, Gómez Casares, M Teresa, Ayala Diaz, Rosa, Xicoy Cirici, Blanca, Ferrer-Marín, Francisca, Ortí, Guillermo, De Paz Arias, Raquel, Ossorio Prendes, Santiago, Pérez López, Raúl, Mora Castera, Elvira, Ruiz Nuño, Concepcion, Jimenez, Antonio, Boque Genovard, Concepcion, Sierra, Magdalena, Martinez-Lopez, Joaquín
Publicado 2023

Immediate Effects of Dasatinib on the Migration and Redistribution of Naïve and Memory Lymphocytes Associated With Lymphocytosis in Chronic Myeloid Leukemia Patients

por Colom-Fernández, Beatriz, Kreutzman, Anna, Marcos-Jiménez, Ana, García-Gutiérrez, Valentín, Cuesta-Mateos, Carlos, Portero-Sainz, Itxaso, Pérez-García, Yaiza, Casado, Luis Felipe, Sánchez-Guijo, Fermín, Martínez-López, Joaquín, Ayala, Rosa M., Boqué, Concha, Xicoy, Blanca, Montero, Isabel, Soto, César, Paz, Raquel, Silva, Gabriela, Vega-Piris, Lorena, Steegmann, Juan Luis, Muñoz-Calleja, Cecilia
Publicado 2019

PB1962: INFLUENCE OF TRANSCRIPT TYPES IN SUSTAINED DEEP MOLECULAR RESPONSE (SDMR) AND TREATMENT-FREE REMISSION (TFR) IN CHRONIC PHASE-CHRONIC MYELOID LEUKEMIA (CP-CML) PATIENTS TRE...

por Torra, Silvia Marce, Méndez, Aleix, Sturla, Antonella Luciana, Ratia, Miriam, Figueras, Anna Angona, Amat, Paula, Ferrer-Marín, Francisca, Escribano, Silvia, Scalzulli, Emilia, Sansa, Montserrat Cortes, Plensa, Esther, Estrada, Natalia, Marco, Marta Cabezon, Morgades, Mireia, Magan, Maria Alicia Senin, Hernandez-Boluda, Juan Carlos, Anguita, Eduardo, Breccia, Massimo, García-Gutiérrez, Valentín, Cirici, Blanca Xicoy, Zamora, Lurdes
Publicado 2023

A BCR-ABL1 cutoff of 1.5% at 3 months, determined by the GeneXpert system, predicts an optimal response in patients with chronic myeloid leukemia

por García-Gutiérrez, Valentín, Gómez-Casares, María T., Puerta, José M., Alonso-Domínguez, Juan M., Osorio, Santiago, Hernández-Boluda, Juan C., Collado, Rosa, Ramírez, María J., Ibáñez, Fátima, Martín, María L., Rodríguez-Gambarte, Juan D., Martínez-Laperche, Carolina, Gómez, Montse, Fiallo, Dolly V., Redondo, Sara, Rodríguez, Alicia, Ruiz-Nuño, Concepción, Steegmann, Juan L., Jiménez-Velasco, Antonio
Publicado 2017

Low-risk polycythemia vera treated with phlebotomies: clinical characteristics, hematologic control and complications in 453 patients from the Spanish Registry of Polycythemia Vera

por Triguero, Ana, Pedraza, Alexandra, Pérez-Encinas, Manuel, Mata-Vázquez, María Isabel, Vélez, Patricia, Fox, Laura, Gómez-Calafat, Montse, García-Delgado, Regina, Gasior, Mercedes, Ferrer-Marín, Francisca, García-Gutiérrez, Valentín, Angona, Anna, Gómez-Casares, María Teresa, Cuevas, Beatriz, Martínez, Clara, Pérez, Raúl, Raya, José María, Guerrero, Lucía, Murillo, Ilda, Bellosillo, Beatriz, Hernández-Boluda, Juan Carlos, Sanz, Cristina, Álvarez-Larrán, Alberto
Publicado 2022

Impact of the COVID-19 pandemic on the diagnosis and treatment of onco-hematologic patients: a discussion paper

por Bouza, Emilio, Martin, Miguel, Alés, José Enrique, Aragonés, Nuria, Barragán, Begoña, de la Cámara, Rafael, Pozo, José Luis Del, García-Gutiérrez, Valentín, García-Sanz, Ramón, Gracia, Diego, Guillem, Vicente, Jiménez-Yuste, Víctor, Martin-Delgado, Mari Cruz, Martínez, Joaquín, López, Rafael, Rodríguez-Lescure, Álvaro, Galiana, Julián Ruiz, Sureda, Ana María, Tejerina-Picado, Francisco, Trilla, Antoni, Zapatero, Antonio, Palomo, Esteban, San-Miguel, Jesús
Publicado 2022

Asciminib vs bosutinib in chronic-phase chronic myeloid leukemia previously treated with at least two tyrosine kinase inhibitors: longer-term follow-up of ASCEMBL

por Hochhaus, Andreas, Réa, Delphine, Boquimpani, Carla, Minami, Yosuke, Cortes, Jorge E., Hughes, Timothy P., Apperley, Jane F., Lomaia, Elza, Voloshin, Sergey, Turkina, Anna, Kim, Dong-Wook, Abdo, Andre, Fogliatto, Laura Maria, le Coutre, Philipp, Sasaki, Koji, Kim, Dennis Dong Hwan, Saussele, Susanne, Annunziata, Mario, Chaudhri, Naeem, Chee, Lynette, García-Gutiérrez, Valentin, Kapoor, Shruti, Allepuz, Alex, Quenet, Sara, Bédoucha, Véronique, Mauro, Michael J.
Publicado 2023

Application of IPSET-thrombosis in 1366 Patients Prospectively Followed From the Spanish Registry of Essential Thrombocythemia

por Alvarez-Larrán, Alberto, Cuevas, Beatriz, Velez, Patricia, Noya, Soledad, Caballero-Navarro, Gonzalo, Ferrer-Marín, Francisca, Carbonell, Sara, Pérez-Encinas, Manuel, Gómez-Casares, María Teresa, Pérez-López, Raúl, Magro, Elena, Moretó, Ana, Pastor-Galán, Irene, Angona, Anna, Mata-Vázquez, María Isabel, Guerrero-Fernández, Lucía, Guerra, José María, Carreño-Tarragona, Gonzalo, Fox, Laura, Murillo, Ilda, García-Gutiérrez, Valentín, Mora, Elvira, Stuckey, Ruth, Arellano-Rodrigo, Eduardo, Hernández-Boluda, Juan Carlos, Pereira, Arturo
Publicado 2023